| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |